Lugano, April 15, 2025 – Swisseutic is pleased to announce a strategic distribution partnership with Qinghai Lake Pharmaceutical Co., Ltd. (QHL), a globally renowned leader in the manufacturing of licorice derivatives.
Founded in 1987 in the Qinghai region of the Tibetan Plateau, QHL is one of the most ancient and established manufacturers of licorice derivatives worldwide. The company specializes in high-quality licorice-based ingredients, including Ammonium Glycyrrhizinate (also known as MAG or Monoammonium Glycyrrhizinate), Dipotassium Glycyrrhizinate, Enoxolone (Glycyrrhetinic Acid), Glycyrrhizic Acid and purified licorice extracts such as Glabridin and Licochalcone A. These ingredients are widely used as food flavorings, pharmaceutical excipients, and cosmetic actives, among other applications.
Swisseutic, based in Lugano, Switzerland, is a company specializing in the distribution of natural ingredients. Founded by Christian Artaria, an industry expert with extensive experience, Swisseutic has quickly established itself as a trusted partner for high-quality ingredients in the pharmaceutical, food, nutraceutical, and cosmetic sectors.
Christian Artaria, Founder and President of Swisseutic, expressed his enthusiasm for the partnership: Christian Artaria, Founder and President of Swisseutic, expressed his enthusiasm for the partnership: “We are honored to represent QHL in Europe, a company that shares our commitment to excellence. This partnership perfectly aligns with Swisseutic’s mission, which is to select and supply the highest-quality natural ingredients, capable of meeting the most rigorous quality standards, in order to best support our European clientele across a wide range of sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food.”
Through this collaboration, Swisseutic strengthens its portfolio by bringing QHL’s premium licorice derivatives to the European market, further reinforcing its position as a reliable partner in the pharmaceutical, food, and cosmetic industries.
Oliver Luo, CEO of QHL, shared his satisfaction with the partnership: “We are delighted to collaborate with Christian and the Swisseutic team. This partnership will allow us to expand our presence in Europe and better serve our customers with high-quality licorice derivatives.”
This collaboration marks an important step forward for both companies, combining QHL’s deep expertise in licorice derivatives with Swisseutic’s robust distribution network and market knowledge. Together, Swisseutic and QHL are committed to fully unlocking the potential of licorice by promoting its excellence and expanding its applications across the nutraceutical, pharmaceutical, food, and cosmetic industries throughout Europe.
*** ***
About Qinghai Lake Pharmaceutical Co., Ltd. (QHL)
Founded in 1987, Qinghai Lake Pharmaceutical Co., Ltd. (QHL) is a leading manufacturer of licorice derivatives. With a team of 80 employees, the company is located in the Qinghai region of the Tibetan Plateau, at an altitude of 2,800 meters, near Qinghai Lake – the largest lake in China, renowned for its alkaline waters.
QHL holds a pharmaceutical license and is ISO 9001 certified. Its sister company, Qinghai Blicsweet Licorice Technology Development Co., Ltd., holds a food license and is certified ISO 9001, ISO 22000, FSSC 22000, ISO 27001, ISO 45001, HACCP, Sedex and Cybervadis.
The company has successfully obtained CEP certification for its Ammonium glycyrrhizinate and holds a REACH certificate for Enoxolone and Dipotassium glycyrrhizinate. Additionally, all its licorice derivatives used in cosmetics are COSMOS-approved, CSAR registered and all products are certified vegan by The Vegan Society, OU Kosher and Halal.
Further Information on Qinghai Lake Pharmaceutical Co., Ltd.: www.qhlpharma.cn
About Swisseutic
Swisseutic SA specializes in supplying premium ingredients to the nutraceutical, pharmaceutical, food, feed, and cosmetic industries.
Swisseutic is built upon 25 years of expertise in the development, production, clinical validation, registration, and marketing of natural products. This wealth of knowledge extends across plant-based preparations (botanicals), encompassing highly purified products obtained directly from plants, as well as those produced through chemical or enzymatic modifications, fermentation technologies, or innovative processes such as production through photobioreactors. Swisseutic objective extends beyond being the primary distributor of botanical extracts; we aspire to be a trusted partner, adept at addressing any concerns related to the quality or availability of these products through a personalized and responsive service.
Further Information on Swisseutic: www.swisseutic.com
*** ***
Noain, Navarra. Spain & Lugano, Switzerland – 22nd of October 2024 – Arandovo S.L., a leader in natural health product innovation, has entered into an exclusive distribution agreement with Swisseutic for the DACH region (Germany, Austria, and Switzerland). This partnership will bring MKARE®, Arandovo’s flagship product, to a new audience across these markets.
MKARE® is the only product on the market made using fresh eggshell membrane. By utilizing fresh membrane and a gentle hydromechanical separation process, the integrity of the native proteins is preserved, ensuring optimal levels of collagen, hyaluronic acid, and elastin. The result is a superior quality product that is truly unique.
Through this agreement, Arandovo aims to leverage Swisseutic’s strong presence in the DACH region to facilitate the introduction of MKARE® to local pharmaceutical, nutraceutical, and food companies. The goal is to offer businesses an innovative, vegetarian product supported by clinical evidence that enhances their portfolio of solutions for the well-being of joints, skin, and connective tissues. With MKARE®, these companies will be able to meet the growing demand for natural, high-quality products in the health and wellness sector.
Christian Artaria, CEO of Swisseutic, expressed his enthusiasm for the partnership: “We are very pleased to embark on this collaboration with Arandovo. MKARE® is an excellent example of innovation in the functional ingredients sector for the food and nutraceutical industries, where the integration of a cutting-edge production process with an optimized supply chain has resulted in a product with a unique and highly effective composition. We are confident that MKARE® will be well-received by our partners, as it meets the needs of a constantly evolving market that increasingly seeks superior quality solutions backed by solid scientific evidence”.
Maria Eugenia Sadaba, General Manager at Arandovo S.L., highlighted the significance of the collaboration: “With over two decades of experience in marketing scientifically validated branded ingredients, Christian Artaria and the Swisseutic team bring unmatched expertise to this partnership. Their profound knowledge of the DACH market, combined with a commitment to excellence, aligns perfectly with our vision. Together, we are excited to introduce MKARE® to new consumers, confident in its ability to deliver unique health benefits and improve well-being.”
*** ***
Arandovo S.L., part of the Pascual Group – a renowned Spanish family-owned company with over 50 years of experience in the food and beverage industry – specializes in innovative health products sourced from Eggshell Membrane. The flagship product, MKARE®, is crafted from fresh Eggshell Membrane using a gentle hydromechanical process, ensuring maximum biological efficacy and preserving the full benefits of its natural components.
Thanks to an exclusive and gentle hydromechanical separation process and the use of fresh egg membrane, MKARE® preserves the integrity of both soluble and insoluble proteins present in the egg shell membrane, ensuring maximum biological efficacy. The in-situ production process allows for a greater integrity of soluble proteins such as ovotransferrin and ovocalixin-36 compared to other typical egg membrane proteins, especially when compared to products derived from shells stored at room temperature before processing. Two key studies demonstrate the efficacy of MKARE®. The first, a chemical characterization study, highlights how MKARE® stands out from degraded egg membrane products by preserving the essential bioactive proteins needed for its effectiveness. The second, a mechanistic study, confirms the product’s dual action, showing both anti-inflammatory effects and regenerative action on human chondrocyte cells. Additionally, MKARE® is supported by three clinical studies, including one already published1, a pilot study, and another currently in publication in the “beauty from within” sector.
To find out more, visit: www.arandovo.com
Swisseutic specializes in supplying premium ingredients to the nutraceutical, pharmaceutical, food, feed, and cosmetic industries.
Swisseutic is built upon 25 years of expertise in the development, production, clinical validation, registration, and marketing of natural products. This wealth of knowledge extends across plant-based preparations (botanicals), encompassing highly purified products obtained directly from plants, as well as those produced through chemical or enzymatic modifications, fermentation technologies, or innovative processes such as production through photobioreactors. Swisseutic objective extends beyond being the primary distributor of botanical extracts; we aspire to be a trusted partner, adept at addressing any concerns related to the quality or availability of these products through a personalized and responsive service.
Further Information on Swisseutic: www.swisseutic.com
*** ***
Marketers of finished products containing the ingredient described herein are responsible for determining whether the claims made for such products are lawful and in compliance with the laws of the country in which they will market the products. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*** ***
Amunì™ is a premium line of Sicilian botanical extracts developed by Nexus, combining the rich agricultural traditions of Sicily with cutting-edge scientific innovation. The product range features natural ingredients like citrus fruits, prickly pear, and pomegranate, designed to support health and wellness in the nutraceutical sector.
An Acronym That Tells a Story:
Amunì™ is inspired by the essence of Sicily, a land rich in history, vibrant colors, and diverse flavors. In Sicilian, “amuni” (or “amunì” in Italian) means “let’s go” or “come on,” a lively expression used to inspire action and forward momentum. The name not only reflects this call to energy and movement but also serves as an acronym that embodies the brand’s mission: “Advance – Mediterranean – Uniqueness – Nutrition – Innovation”. Through direct collaboration with local producers, Nexus ensures the careful selection of all the plant-based raw materials that make up the unique offerings of Amunì. Sicilian citrus fruits, known for their high content of vitamin C and antioxidants, provide anti-inflammatory benefits and support the immune system. Prickly pear, renowned for its antioxidant and hydrating properties, is ideal for sports nutrition. Pomegranate, rich in polyphenols, helps improve cardiovascular health. Moreover, an innovative blend of “Carota Novella di Ispica” and red pepper, rich in lycopene and beta-carotene, is essential for skin and eye health. The Amunì line also includes ingredients such as capers grown in Pantelleria, yellow cherry tomatoes from Pachino, Camone tomatoes, carob, watermelon, cucumbers, rosemary, and others in development, all ready to contribute further to well-being.
To find out more, visit www.amunibotanicalextracts.com
*** ***
My journey into the captivating realm of botanicals began 25 years ago. From that pivotal moment, I discerned that this was the domain in which I desired to carve out my career path. With each passing venture, my passion for this profession has flourished. This has driven me to immerse myself in the intricacies and hidden nuances of the industry. Over the course of these 25 years, I’ve traversed the globe, delving into the cultivation and harvesting practices of medicinal plants, recognizing the paramount importance of these initial phases in ensuring the quality of each product. I have developed multiple products, been involved in production, clinically validated many and registered them internationally, and, of course, presented and marketed them worldwide.
This knowledge base traverses’ various plant-based preparations, encompassing highly refined products extracted directly from plants, as well as those meticulously crafted through chemical or enzymatic modifications and innovative methodologies such as production through photobioreactors.
It brings me immense joy to announce today the birth of Swisseutic. It is a culmination of the expertise amassed over decades in the development, production, clinical validation, registration, and marketing of natural products on a global scale.
At the core of Swisseutic lies a steadfast commitment to the scrupulous selection of premium natural ingredients, aimed at fostering transparency throughout the production chain and raising awareness regarding the paramount importance of ingredient quality in the market.
Together, we at Swisseutic aspire to redefine industry standards, innovate, and cultivate a future where excellence and integrity serve as the defining pillars of the natural product landscape.
Thank you for embarking on this extraordinary journey with us.
Warm regards,
Christian Artaria